Open AccessINHIBITION OF PUERPERAL LACTATION
Author(s) -
Dewhurst C. J.,
Harrison Robert F.,
Biswas S.
Publication year - 1977
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016347709154987
Subject(s) - bromocriptine , medicine , lactation , placebo , prolactin , breastfeeding , breast feeding , menstruation , endocrinology , obstetrics , anesthesia , hormone , pregnancy , pediatrics , alternative medicine , pathology , biology , genetics
. Bromocriptine and placebo were randomly allocated for three weeks to 52 postpartum patients requiring lactation suppression. Bromocriptine significantly lowered plasma prolactin levels and suppressed breast milk, breast pain and engorgement quicker than placebo. No side‐effects were noted and rebound lactation did not occur. Menstruation appeared to re‐start sooner when Bromocriptine was given.